Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
74
Zitationen
15
Autoren
2024
Jahr
Abstract
2-[<sup>18</sup>F]FDG PET/CT is extremely useful in BC management, as supported by extensive evidence of its utility compared to other imaging modalities in several clinical scenarios.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 29.094 Zit.
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 · 28.351 Zit.
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · 21.349 Zit.
Robust uncertainty principles: exact signal reconstruction from highly incomplete frequency information
2006 · 15.714 Zit.
Image processing with ImageJ
2004 · 11.903 Zit.
Autoren
Institutionen
- Champalimaud Foundation(PT)
- Leiden University Medical Center(NL)
- Université Claude Bernard Lyon 1(FR)
- Inserm(FR)
- Délégation Paris 7(FR)
- Université Paris Cité(FR)
- Hôpital Saint-Louis(FR)
- St Thomas' Hospital(GB)
- King's College London(GB)
- University of Southern California(US)
- Hoag Memorial Hospital Presbyterian(US)
- Brigham and Women's Hospital(US)
- Harvard University(US)
- Dana-Farber Cancer Institute(US)
- Dana-Farber Brigham Cancer Center(US)
- Clinica Universidad de Navarra(ES)
- The Netherlands Cancer Institute(NL)
- Amsterdam University Medical Centers(NL)
- University of Antwerp(BE)
- Iridium Kankernetwerk(BE)
- Radboud University Nijmegen(NL)
- Providence College(US)
- Brown University(US)
- Lifespan(US)
- University of Twente(NL)
- Delft University of Technology(NL)